.jpg)
In the design of sustained-release active ingredients for tablets, the two most commonly engineered and utilized systems are the reservoir system and the matrix system:
Reservoir system: Characterized by a "core-shell" structure, in which the active pharmaceutical ingredient (API) acts as the reservoir core, completely surrounded by a polymer membrane layer that functions as a rate-controlling barrier.
Matrix system: A structure in which the API is homogeneously dispersed as molecules or solid particles within a matrix network, forming a single solid mass.
Compared to the reservoir system, the matrix system offers distinct advantages in safety and the ability to control the API release rate. In some cases, if the tablet fractures, the sustained-release property of the matrix system is only partially affected rather than completely lost, unlike the reservoir system. Furthermore, utilizing a matrix system helps mitigate the risk of dose dumping, which could cause a patient overdose if the tablet undergoes mechanical breakage.
.jpeg)
The matrix system does not possess a fixed barrier membrane; the release-controlling excipient is the drug mass itself. As the drug in the outermost layer is released, the dissolution medium must penetrate deeper into the interior to access the subsequent layers of the drug.
The API release process from a matrix system occurs through three specific mechanisms, depending on the nature of the polymer used:
Hydrophobic matrix system: The tablet maintains its original shape and size throughout the dissolution process. The API is completely released through a gradual diffusion mechanism via the porous capillary network within the matrix.
Swellable matrix system: Upon contact with gastrointestinal fluids, the tablet surface hydrates and swells to form a viscous gel layer. This gel layer acts as a controlling barrier; the API must diffuse through this gel layer to exit into the surrounding environment.
Erodible matrix system: The tablet size gradually decreases over time due to the erosion or dissolution of the excipient matrix. The API release rate depends directly on the erosion rate of this matrix.
| Classification | Typical Excipients | Characteristics & Release Mechanism | Advantages | Disadvantages |
|---|---|---|---|---|
| Hydrophilic matrix system | HPMC, Xanthan gum, Sodium Alginate, PVP K90 | Hydrates and swells to form a viscous gel barrier upon contact with gastric fluid.
Release occurs via diffusion and erosion of the gel layer. | - High biocompatibility, safe.
- Easy to adjust the release rate via viscosity grades.
- Simple manufacturing process. | - The gel network can rupture prematurely due to solid food or strong intestinal peristalsis.
- Less stable if using natural polymers (degraded by colonic microflora). |
| Lipid matrix system | Glyceryl behenate, hydrogenated castor oil, Carnauba wax, beeswax | Forms a hydrophobic, porous, and insoluble matrix.
Drug release occurs via diffusion or matrix erosion under the influence of enzymes/pH. | - Highly effective in retarding highly water-soluble APIs.
- The lipid matrix has high mechanical stability.
- Some excipients also act as lubricants. | - Highly variable release rate due to lipase enzymes or high-fat foods.
- Requires more complex formulation techniques (solid dispersion, melt granulation, hot melt extrusion). |
| Inert / insoluble matrix system | Ethyl Cellulose (EC), PVC, Eudragit RS/RL | Non-swelling, non-disintegrating, retains its shape.
Complete drug release due to diffusion through the porous capillary network within the matrix. | - Constant, predictable release kinetics.
- Unaffected by changes in pH and digestive enzymes. | - Non-biodegradable (the "ghost tablet" excreted in feces may cause patient anxiety).
- Poorly soluble APIs can get trapped deep within the capillary core, failing to release completely. |
(1).jpg)
